Yesterday the outgoing President of the United States Barack Obama signed into law the 21st Century Cures Act, which has been called the most momentous health legislation in the country since t
Astellas has added another gene therapy to its pipeline, taking an option on a clinical-stage candidate for a rare genetic form of dementia from UK biotech AviadoBio for around $50 million.
